Patent · US Active

Anti-VEGF protein compositions and methods for producing the same

US11174283B2 · kind B2 · utility

10Cited by
68References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 18, 2021
Grant dateNov 16, 2021
Priority date
Expiry dateMar 18, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2030/027
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure pertains to compositions comprising aflibercept and methods for producing such compositions in chemically defined media and using chromatography to reduce amounts of certain aflibercept variants.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.